Proteomic and Bioinformatic Investigation of Altered Pathways in Neuroglobin-Deficient Breast Cancer Cells

Neuroglobin (NGB) is a myoglobin-like monomeric globin that is involved in several processes, displaying a pivotal redox-dependent protective role in neuronal and extra-neuronal cells. NGB remarkably exerts its function upon upregulation by NGB inducers, such as 17β-estradiol (E2) and H<sub>2&...

Full description

Bibliographic Details
Main Authors: Michele Costanzo, Marco Fiocchetti, Paolo Ascenzi, Maria Marino, Marianna Caterino, Margherita Ruoppolo
Format: Article
Language:English
Published: MDPI AG 2021-04-01
Series:Molecules
Subjects:
Online Access:https://www.mdpi.com/1420-3049/26/8/2397
_version_ 1797537007473262592
author Michele Costanzo
Marco Fiocchetti
Paolo Ascenzi
Maria Marino
Marianna Caterino
Margherita Ruoppolo
author_facet Michele Costanzo
Marco Fiocchetti
Paolo Ascenzi
Maria Marino
Marianna Caterino
Margherita Ruoppolo
author_sort Michele Costanzo
collection DOAJ
description Neuroglobin (NGB) is a myoglobin-like monomeric globin that is involved in several processes, displaying a pivotal redox-dependent protective role in neuronal and extra-neuronal cells. NGB remarkably exerts its function upon upregulation by NGB inducers, such as 17β-estradiol (E2) and H<sub>2</sub>O<sub>2</sub>. However, the molecular bases of NGB’s functions remain undefined, mainly in non-neuronal cancer cells. Human MCF-7 breast cancer cells with a knocked-out (KO) <i>NGB</i> gene obtained using CRISPR/Cas9 technology were analyzed using shotgun label-free quantitative proteomics in comparison with control cells. The differential proteomics experiments were also performed after treatment with E2, H<sub>2</sub>O<sub>2</sub>, and E2 + H<sub>2</sub>O<sub>2</sub>. All the runs acquired using liquid chromatography–tandem mass spectrometry were elaborated within the same MaxQuant analysis, leading to the quantification of 1872 proteins in the global proteomic dataset. Then, a differentially regulated protein dataset was obtained for each specific treatment. After the proteomic study, multiple bioinformatics analyses were performed to highlight unbalanced pathways and processes. Here, we report the proteomic and bioinformatic investigations concerning the effects on cellular processes of NGB deficiency and cell treatments. Globally, the main processes that were affected were related to the response to stress, cytoskeleton dynamics, apoptosis, and mitochondria-driven pathways.
first_indexed 2024-03-10T12:08:58Z
format Article
id doaj.art-ba72553199f74ecba52f2d9ab4b2d604
institution Directory Open Access Journal
issn 1420-3049
language English
last_indexed 2024-03-10T12:08:58Z
publishDate 2021-04-01
publisher MDPI AG
record_format Article
series Molecules
spelling doaj.art-ba72553199f74ecba52f2d9ab4b2d6042023-11-21T16:23:01ZengMDPI AGMolecules1420-30492021-04-01268239710.3390/molecules26082397Proteomic and Bioinformatic Investigation of Altered Pathways in Neuroglobin-Deficient Breast Cancer CellsMichele Costanzo0Marco Fiocchetti1Paolo Ascenzi2Maria Marino3Marianna Caterino4Margherita Ruoppolo5Department of Molecular Medicine and Medical Biotechnology, School of Medicine, University of Naples Federico II, 80131 Naples, ItalyDepartment of Science, University Roma Tre, 00146 Rome, ItalyDepartment of Science, University Roma Tre, 00146 Rome, ItalyDepartment of Science, University Roma Tre, 00146 Rome, ItalyDepartment of Molecular Medicine and Medical Biotechnology, School of Medicine, University of Naples Federico II, 80131 Naples, ItalyDepartment of Molecular Medicine and Medical Biotechnology, School of Medicine, University of Naples Federico II, 80131 Naples, ItalyNeuroglobin (NGB) is a myoglobin-like monomeric globin that is involved in several processes, displaying a pivotal redox-dependent protective role in neuronal and extra-neuronal cells. NGB remarkably exerts its function upon upregulation by NGB inducers, such as 17β-estradiol (E2) and H<sub>2</sub>O<sub>2</sub>. However, the molecular bases of NGB’s functions remain undefined, mainly in non-neuronal cancer cells. Human MCF-7 breast cancer cells with a knocked-out (KO) <i>NGB</i> gene obtained using CRISPR/Cas9 technology were analyzed using shotgun label-free quantitative proteomics in comparison with control cells. The differential proteomics experiments were also performed after treatment with E2, H<sub>2</sub>O<sub>2</sub>, and E2 + H<sub>2</sub>O<sub>2</sub>. All the runs acquired using liquid chromatography–tandem mass spectrometry were elaborated within the same MaxQuant analysis, leading to the quantification of 1872 proteins in the global proteomic dataset. Then, a differentially regulated protein dataset was obtained for each specific treatment. After the proteomic study, multiple bioinformatics analyses were performed to highlight unbalanced pathways and processes. Here, we report the proteomic and bioinformatic investigations concerning the effects on cellular processes of NGB deficiency and cell treatments. Globally, the main processes that were affected were related to the response to stress, cytoskeleton dynamics, apoptosis, and mitochondria-driven pathways.https://www.mdpi.com/1420-3049/26/8/2397neuroglobin17β-estradiollabel-free proteomicsbioinformaticspathway analysisoxidative stress
spellingShingle Michele Costanzo
Marco Fiocchetti
Paolo Ascenzi
Maria Marino
Marianna Caterino
Margherita Ruoppolo
Proteomic and Bioinformatic Investigation of Altered Pathways in Neuroglobin-Deficient Breast Cancer Cells
Molecules
neuroglobin
17β-estradiol
label-free proteomics
bioinformatics
pathway analysis
oxidative stress
title Proteomic and Bioinformatic Investigation of Altered Pathways in Neuroglobin-Deficient Breast Cancer Cells
title_full Proteomic and Bioinformatic Investigation of Altered Pathways in Neuroglobin-Deficient Breast Cancer Cells
title_fullStr Proteomic and Bioinformatic Investigation of Altered Pathways in Neuroglobin-Deficient Breast Cancer Cells
title_full_unstemmed Proteomic and Bioinformatic Investigation of Altered Pathways in Neuroglobin-Deficient Breast Cancer Cells
title_short Proteomic and Bioinformatic Investigation of Altered Pathways in Neuroglobin-Deficient Breast Cancer Cells
title_sort proteomic and bioinformatic investigation of altered pathways in neuroglobin deficient breast cancer cells
topic neuroglobin
17β-estradiol
label-free proteomics
bioinformatics
pathway analysis
oxidative stress
url https://www.mdpi.com/1420-3049/26/8/2397
work_keys_str_mv AT michelecostanzo proteomicandbioinformaticinvestigationofalteredpathwaysinneuroglobindeficientbreastcancercells
AT marcofiocchetti proteomicandbioinformaticinvestigationofalteredpathwaysinneuroglobindeficientbreastcancercells
AT paoloascenzi proteomicandbioinformaticinvestigationofalteredpathwaysinneuroglobindeficientbreastcancercells
AT mariamarino proteomicandbioinformaticinvestigationofalteredpathwaysinneuroglobindeficientbreastcancercells
AT mariannacaterino proteomicandbioinformaticinvestigationofalteredpathwaysinneuroglobindeficientbreastcancercells
AT margheritaruoppolo proteomicandbioinformaticinvestigationofalteredpathwaysinneuroglobindeficientbreastcancercells